BRPI0821301A2 - Composto de aspirinato de isossorbida, composto carregador, composto medicamentoso, composição farmacêutica, e, uso de um composto - Google Patents
Composto de aspirinato de isossorbida, composto carregador, composto medicamentoso, composição farmacêutica, e, uso de um compostoInfo
- Publication number
- BRPI0821301A2 BRPI0821301A2 BRPI0821301-1A BRPI0821301A BRPI0821301A2 BR PI0821301 A2 BRPI0821301 A2 BR PI0821301A2 BR PI0821301 A BRPI0821301 A BR PI0821301A BR PI0821301 A2 BRPI0821301 A2 BR PI0821301A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- carrier
- drug
- isosorbide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE20070934A IE20070934A1 (en) | 2007-12-21 | 2007-12-21 | Efficient aspirin prodrugs |
IE2007/0934 | 2007-12-21 | ||
PCT/EP2008/068114 WO2009080795A1 (en) | 2007-12-21 | 2008-12-19 | Efficient aspirin prodrugs |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0821301A2 true BRPI0821301A2 (pt) | 2015-06-16 |
BRPI0821301B1 BRPI0821301B1 (pt) | 2019-05-21 |
BRPI0821301B8 BRPI0821301B8 (pt) | 2019-06-04 |
Family
ID=40428154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0821301A BRPI0821301B8 (pt) | 2007-12-21 | 2008-12-19 | composto de aspirinato de isossorbida, composição farmacêutica, e, seu uso |
Country Status (14)
Country | Link |
---|---|
US (1) | US8486974B2 (pt) |
EP (1) | EP2222681B1 (pt) |
JP (1) | JP5524857B2 (pt) |
CN (1) | CN101925604B (pt) |
AU (1) | AU2008339961B2 (pt) |
BR (1) | BRPI0821301B8 (pt) |
CA (1) | CA2709432C (pt) |
EA (1) | EA022878B1 (pt) |
IE (1) | IE20070934A1 (pt) |
IL (1) | IL206424A (pt) |
MX (1) | MX2010006878A (pt) |
NZ (1) | NZ586304A (pt) |
WO (1) | WO2009080795A1 (pt) |
ZA (1) | ZA201004371B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2606565C (en) | 2005-05-27 | 2016-05-10 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
JP5441928B2 (ja) * | 2008-02-07 | 2014-03-12 | ニコックス エス エイ | 一酸化窒素供与化合物 |
WO2010009210A2 (en) * | 2008-07-17 | 2010-01-21 | Schering Corporation | Acetylsalicyclic acid derivatives useful to treat metabolic syndromes |
WO2010044875A2 (en) * | 2008-10-16 | 2010-04-22 | Novan, Inc. | Nitric oxide releasing particles for oral care applications |
US9526738B2 (en) | 2009-08-21 | 2016-12-27 | Novan, Inc. | Topical gels and methods of using the same |
DK2467173T3 (da) | 2009-08-21 | 2019-07-29 | Novan Inc | Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf |
EP2488591A1 (en) * | 2009-10-13 | 2012-08-22 | Novan, Inc. | Nitric oxide-releasing coatings |
US8834858B2 (en) | 2010-07-02 | 2014-09-16 | Solvotrin Therapeutics Ltd. | Treatment for dyslipidemia |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
EP2665730B1 (en) | 2011-01-21 | 2019-07-24 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Compounds with super-aspirin effects |
EP2681286B1 (en) | 2011-02-28 | 2018-08-15 | Novan, Inc. | Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same |
CN102757444B (zh) * | 2011-04-29 | 2016-02-10 | 南京信诺泰医药有限公司 | 具有一氧化氮供体性质的苯并呋喃类化合物 |
CN102225940A (zh) * | 2011-05-06 | 2011-10-26 | 中国药科大学 | 一种苯甲酸异山梨醇酯类化合物、其制备方法及医药用途 |
WO2014052889A1 (en) * | 2012-09-27 | 2014-04-03 | The Board Of Trustees Of The University Of Illinois | Anti-inflammatory agents |
CN103193789A (zh) * | 2013-03-14 | 2013-07-10 | 中国药科大学 | 一种光学活性的丁苯酞开环衍生物、制备方法及医药用途 |
US9441164B2 (en) * | 2013-07-31 | 2016-09-13 | Semiconductor Energy Laboratory Co., Ltd. | Isosorbide derivative, liquid crystal composition, liquid crystal element, and liquid crystal display device |
WO2015138224A1 (en) * | 2014-03-13 | 2015-09-17 | Sears Barry D | Compositions and methods for reducing chronic low-level inflammation |
WO2016135037A1 (en) * | 2015-02-23 | 2016-09-01 | Nitto Denko Corporation | Dianhydrohexitol codrug |
EP3273951B1 (en) | 2015-03-27 | 2020-07-29 | Symbionyx Pharmaceuticals Inc. | Compositions and methods for treating psoriasis |
EP3287462A1 (en) * | 2016-08-25 | 2018-02-28 | Nitto Denko Corporation | Isosorbide derivatives to treat bacterial biofilms |
GB2560769B (en) * | 2017-03-24 | 2020-04-08 | Solvotrin Therapeutics Ltd | Compounds and compositions for use in treating psoriasis |
CN109384759B (zh) * | 2018-12-18 | 2019-07-23 | 上海槐丰生物科技有限公司 | 一种药物化合物及其制备与用途 |
CN113683623B (zh) * | 2021-09-09 | 2022-08-12 | 中国人民解放军空军军医大学 | 一种no供体化合物及其制备方法和用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017673A1 (en) * | 1996-10-21 | 1998-04-30 | Cal International Limited | Isosorbide aspirinate esters |
ES2142773B1 (es) | 1998-10-07 | 2001-01-01 | Lacer Sa | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida. |
ES2258365B1 (es) | 2003-10-03 | 2007-12-01 | Lacer, S.A. | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
CN1618798A (zh) | 2004-02-25 | 2005-05-25 | 鲁南制药股份有限公司 | 单硝酸异山梨酯的制备方法 |
US8834858B2 (en) | 2010-07-02 | 2014-09-16 | Solvotrin Therapeutics Ltd. | Treatment for dyslipidemia |
-
2007
- 2007-12-21 IE IE20070934A patent/IE20070934A1/en not_active Application Discontinuation
-
2008
- 2008-12-19 US US12/808,693 patent/US8486974B2/en active Active
- 2008-12-19 CN CN200880125583.3A patent/CN101925604B/zh active Active
- 2008-12-19 EA EA201000918A patent/EA022878B1/ru not_active IP Right Cessation
- 2008-12-19 MX MX2010006878A patent/MX2010006878A/es active IP Right Grant
- 2008-12-19 CA CA2709432A patent/CA2709432C/en active Active
- 2008-12-19 AU AU2008339961A patent/AU2008339961B2/en not_active Ceased
- 2008-12-19 JP JP2010538776A patent/JP5524857B2/ja active Active
- 2008-12-19 WO PCT/EP2008/068114 patent/WO2009080795A1/en active Application Filing
- 2008-12-19 BR BRPI0821301A patent/BRPI0821301B8/pt not_active IP Right Cessation
- 2008-12-19 NZ NZ586304A patent/NZ586304A/en unknown
- 2008-12-19 EP EP08865246.6A patent/EP2222681B1/en active Active
-
2010
- 2010-06-16 IL IL206424A patent/IL206424A/en active IP Right Grant
- 2010-06-21 ZA ZA2010/04371A patent/ZA201004371B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2222681B1 (en) | 2016-02-17 |
AU2008339961A1 (en) | 2009-07-02 |
CA2709432C (en) | 2018-07-24 |
IE20070934A1 (en) | 2009-06-24 |
BRPI0821301B1 (pt) | 2019-05-21 |
WO2009080795A1 (en) | 2009-07-02 |
US20110046182A1 (en) | 2011-02-24 |
JP2011517657A (ja) | 2011-06-16 |
EA201000918A1 (ru) | 2010-12-30 |
JP5524857B2 (ja) | 2014-06-18 |
CN101925604B (zh) | 2014-11-26 |
EA022878B1 (ru) | 2016-03-31 |
ZA201004371B (en) | 2012-01-25 |
EP2222681A1 (en) | 2010-09-01 |
US8486974B2 (en) | 2013-07-16 |
AU2008339961B2 (en) | 2014-02-13 |
NZ586304A (en) | 2012-07-27 |
IL206424A0 (en) | 2010-12-30 |
IL206424A (en) | 2015-11-30 |
MX2010006878A (es) | 2010-11-30 |
CN101925604A (zh) | 2010-12-22 |
CA2709432A1 (en) | 2009-07-02 |
BRPI0821301B8 (pt) | 2019-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0821301A2 (pt) | Composto de aspirinato de isossorbida, composto carregador, composto medicamentoso, composição farmacêutica, e, uso de um composto | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0819696A2 (pt) | Compostos de derivados de 2-fenil-pirimidina, composição farmacêutica e uso de um composto | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
BRPI0609802A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
BR112013016761A2 (pt) | uso de um composto, composto da fórmula, composição farmacêutica, oligonucleotídeo, conjugado de molécula pequena e um oligonucleotídeo, compostos, uso e métodos | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BRPI0818193A2 (pt) | composto, sal farmacêuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto | |
BRPI0918360A2 (pt) | composto, composição farmacêutica e usos de um composto | |
BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) REF. RPI 2524 DE 21/05/2019 QUANTO AO QUADRO REIVINDICATORIO. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2610 DE 12-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |